12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Melanocortin-4 receptor–regulated energy homeostasis

      research-article
      1 , 2 , 3 , 3 , 4
      Nature neuroscience

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The melanocortin system provides a conceptual blueprint for the central control of energetic state. Defined by four principal molecular components—two antagonistically acting ligands and two cognate receptors—this phylogenetically conserved system serves as a prototype for hierarchical energy balance regulation. Over the last decade the application of conditional genetic techniques has facilitated the neuroanatomical dissection of the melanocortinergic network and identified the specific neural substrates and circuits that underscore the regulation of feeding behavior, energy expenditure, glucose homeostasis and autonomic outflow. In this regard, the melanocortin-4 receptor is a critical coordinator of mammalian energy homeostasis and body weight. Drawing on recent advances in neuroscience and genetic technologies, we consider the structure and function of the melanocortin-4 receptor circuitry and its role in energy homeostasis.

          Related collections

          Author and article information

          Journal
          9809671
          21092
          Nat Neurosci
          Nat. Neurosci.
          Nature neuroscience
          1097-6256
          1546-1726
          6 January 2017
          February 2016
          19 January 2017
          : 19
          : 2
          : 206-219
          Affiliations
          [1 ]Diabetes, Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
          [2 ]National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA
          [3 ]Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
          [4 ]Centre for Integrative Physiology, University of Edinburgh, Edinburgh, UK
          Author notes
          Correspondence should be addressed to A.S.G. ( agarfiel@ 123456staffmail.ed.ac.uk ) or M.J.K. ( michael.krashes@ 123456nih.gov )
          Article
          PMC5244821 PMC5244821 5244821 nihpa840551
          10.1038/nn.4202
          5244821
          26814590
          942a88e2-a6ca-4ae3-b92f-6a76c01bc2e2

          Reprints and permissions information is available online at http://www.nature.com/reprints/index.html.

          History
          Categories
          Article

          Comments

          Comment on this article